Perioperative bleeding is common in patients undergoing noncardiac surgery. Tranexamic acid is an antifibrinolytic drug that may safely decrease such bleeding. We conducted a trial involving patients ...

The CRASH-2 trial investigators sought to determine whether early administration of tranexamic acid would decrease mortality due to bleeding and, by reducing vascular occlusive events, reduce the need ...

Neither tranexamic acid (500 mg/day) nor mefenamic acid (500 mg/day) were able to alleviate "nuisance" bleeding or spotting during the first 90 days after levonorgestrel-releasing intrauterine system ...

A breakthrough could be coming in the way young people recover from surgery to reconstruct the anterior cruciate ligament ...

Please provide your email address to receive an email when new articles are posted on . Adrenaline and tranexamic acid each halted bleeding in 83.1% of patients. Moderate bleeding was stopped more ...

For patients undergoing surgery for elbow trauma, treatment with the hemostatic drug tranexamic acid (TXA) is associated with a decreased incidence of heterotopic ossification (HO) – a common ...

Prophylactic tranexamic acid (TXA) during cesarean delivery did not lead to a lower risk of maternal death or blood transfusion, a randomized trial found. Among 11,000 women in 31 U.S. hospitals ...

Please provide your email address to receive an email when new articles are posted on . For patients with a history of coronary artery disease or coronary stents who undergo total joint arthroplasty, ...

Topical and intravenous tranexamic acid (TXA) were found to significantly reduce blood loss compared with placebo in patients who have undergone bone surgery, suggesting that both administration ...

SCHAUMBURG, Ill.--(BUSINESS WIRE)--Avenacy, a specialty pharmaceutical company focused on supplying critical injectable medications, today announced it has launched Tranexamic Acid Injection, USP in ...